<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35387158</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">2452-199X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>18</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Bioactive materials</Title>
          <ISOAbbreviation>Bioact Mater</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Nanoenzyme engineered neutrophil-derived exosomes attenuate joint injury in advanced rheumatoid arthritis via regulating inflammatory environment.</ArticleTitle>
        <Pagination>
          <StartPage>1</StartPage>
          <EndPage>14</EndPage>
          <MedlinePgn>1-14</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bioactmat.2022.02.017</ELocationID>
        <Abstract>
          <AbstractText>Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by synovitis and destruction of cartilage, promoted by sustained inflammation. However, current treatments remain unsatisfactory due to lacking of selective and effective strategies for alleviating inflammatory environments in RA joint. Inspired by neutrophil chemotaxis for inflammatory region, we therefore developed neutrophil-derived exosomes functionalized with sub-5 nm ultrasmall Prussian blue nanoparticles (uPB-Exo) via click chemistry, inheriting neutrophil-targeted biological molecules and owning excellent anti-inflammatory properties. uPB-Exo can selectively accumulate in activated fibroblast-like synoviocytes, subsequently neutralizing pro-inflammatory factors, scavenging reactive oxygen species, and alleviating inflammatory stress. In addition, uPB-Exo effectively targeted to inflammatory synovitis, penetrated deeply into the cartilage and real-time visualized inflamed joint through MRI system, leading to precise diagnosis of RA <i>in vivo</i> with high sensitivity and specificity. Particularly, uPB-Exo induced a cascade of anti-inflammatory events via Th17/Treg cell balance regulation, thereby significantly ameliorating joint damage. Therefore, nanoenzyme functionalized exosomes hold the great potential for enhanced treatment of RA in clinic.</AbstractText>
          <CopyrightInformation>© 2022 The Authors.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Lei</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, Division of Sports Medicine and Adult Reconstructive Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Branch of National Clinical Research Center for Orthopedics, Sports Medicine and Rehabilitation, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Qin</LastName>
            <ForeName>Ziguo</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Bioelectronics, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing, 210096, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sun</LastName>
            <ForeName>Han</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, Division of Sports Medicine and Adult Reconstructive Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Branch of National Clinical Research Center for Orthopedics, Sports Medicine and Rehabilitation, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Xiang</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, Division of Sports Medicine and Adult Reconstructive Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Branch of National Clinical Research Center for Orthopedics, Sports Medicine and Rehabilitation, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dong</LastName>
            <ForeName>Jian</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, Division of Sports Medicine and Adult Reconstructive Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Branch of National Clinical Research Center for Orthopedics, Sports Medicine and Rehabilitation, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shen</LastName>
            <ForeName>Siyu</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, Division of Sports Medicine and Adult Reconstructive Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Branch of National Clinical Research Center for Orthopedics, Sports Medicine and Rehabilitation, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zheng</LastName>
            <ForeName>Liming</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, Division of Sports Medicine and Adult Reconstructive Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Branch of National Clinical Research Center for Orthopedics, Sports Medicine and Rehabilitation, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gu</LastName>
            <ForeName>Ning</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Bioelectronics, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing, 210096, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiang</LastName>
            <ForeName>Qing</ForeName>
            <Initials>Q</Initials>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, Division of Sports Medicine and Adult Reconstructive Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, PR China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Branch of National Clinical Research Center for Orthopedics, Sports Medicine and Rehabilitation, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Bioact Mater</MedlineTA>
        <NlmUniqueID>101685294</NlmUniqueID>
        <ISSNLinking>2452-199X</ISSNLinking>
      </MedlineJournalInfo>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="ErratumIn">
          <RefSource>Bioact Mater. 2022 May 04;19:486</RefSource>
          <PMID Version="1">35574060</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Advanced rheumatoid arthritis</Keyword>
        <Keyword MajorTopicYN="N">Effective treatment</Keyword>
        <Keyword MajorTopicYN="N">Engineered neutrophil-derived exosomes</Keyword>
        <Keyword MajorTopicYN="N">Inflammation targeting</Keyword>
        <Keyword MajorTopicYN="N">Inflammatory environment regulation</Keyword>
      </KeywordList>
      <CoiStatement>The authors declared that they have no conflicts of interest to this work.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>7</Day>
          <Hour>5</Hour>
          <Minute>21</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35387158</ArticleId>
        <ArticleId IdType="pmc">PMC8961303</ArticleId>
        <ArticleId IdType="doi">10.1016/j.bioactmat.2022.02.017</ArticleId>
        <ArticleId IdType="pii">S2452-199X(22)00079-2</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Aletaha D., Smolen J.S. Diagnosis and management of rheumatoid arthritis: a review. JAMA. 2018;320:1360–1372.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30285183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Firestein G.S. Evolving concepts of rheumatoid arthritis. Nature. 2003;423:356–361.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12748655</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McInnes I.B., Schett G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 2011;365:2205–2219.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22150039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nerurkar L., Siebert S., McInnes I.B., Cavanagh J. Rheumatoid arthritis and depression: an inflammatory perspective. Lancet Psychiatr. 2019;6:164–173.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30366684</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen Z., Bozec A., Ramming A., Schett G. Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis. Nat. Rev. Rheumatol. 2019;15:9–17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30341437</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu D.R., McDavid A.N., Kongpachith S., Lingampalli N., Glanville J., Ju C.H., Gottardo R., Robinson W.H. T cell–dependent affinity maturation and innate immune pathways differentially drive autoreactive B cell responses in rheumatoid arthritis. Arthritis Rheumatol. 2018;70:1732–1744.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6203609</ArticleId>
            <ArticleId IdType="pubmed">29855173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh S., Singh T.G., Mahajan K., Dhiman S. Pharmacology, Medicinal plants used against various inflammatory biomarkers for the management of rheumatoid arthritis. J. Pharm. Pharmacol. 2020;72:1306–1327.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32812250</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morand E., Leech M., Bernhagen J. MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nat. Rev. Drug Discov. 2006;5:399–411.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16628200</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Friedman B., Cronstein B. Methotrexate mechanism in treatment of rheumatoid arthritis. Joint Bone Spine. 2019;86:301–307.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6360124</ArticleId>
            <ArticleId IdType="pubmed">30081197</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lucas C.J., Dimmitt S.B., Martin J.H. Optimising low‐dose methotrexate for rheumatoid arthritis-A review. Br. J. Clin. Pharmacol. 2019;85:2228–2234.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6783593</ArticleId>
            <ArticleId IdType="pubmed">31276602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Favalli E.G., Raimondo M.G., Becciolini A., Crotti C., Biggioggero M., Caporali R.J. The management of first-line biologic therapy failures in rheumatoid arthritis: current practice and future perspectives. Autoimmun. Rev. 2017;16:1185–1195.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29037899</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wruck C.J., Fragoulis A., Gurzynski A., Brandenburg L., Kan Y.W., Chan K., Hassenpflug J., Freitag-Wolf S., Varoga D., Lippross S., Pufe T. Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice. ARD (Ann. Rheum. Dis.) 2011;70:844–850.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21173018</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vasanthi P., Nalini G., Rajasekhar G. Status of oxidative stress in rheumatoid arthritis. Int. J. Rheum. Dis. 2009;12:29–33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20374313</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stamp L.K., Khalilova I., Tarr J.M., Senthilmohan R., Turner R., Haigh R.C., Winyard P.G., Kettle A.J. Myeloperoxidase and oxidative stress in rheumatoid arthritis. Rheumatology. 2012;51:1796–1803.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22814531</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tak P.P., Zvaifler N.J., Green D.R., Firestein G. Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases. Immunol. Today. 2000;21:78–82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10652465</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim J., Kim H.Y., Song S.Y., Go S., Sohn H.S., Baik S., Soh M., Kim K., Kim D., Kim H.C., Lee N., Kim B., Hyeon T. Synergistic oxygen generation and reactive oxygen species scavenging by manganese ferrite/ceria co-decorated nanoparticles for rheumatoid arthritis treatment. ACS Nano. 2019;13:3206–3217.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30830763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He Y., Yue Y., Zheng X., Zhang K., Chen S., Du Z. Curcumin, inflammation, and chronic diseases: how are they linked? Molecules. 2015;20:9183–9213.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6272784</ArticleId>
            <ArticleId IdType="pubmed">26007179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chou T.H., Nugroho D.S., Chang J.Y., Cheng Y.S., Liang C.H., Deng M.J. Encapsulation and characterization of nanoemulsions based on an anti-oxidative polymeric amphiphile for topical apigenin delivery. Polymers. 2021;13:1016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8037426</ArticleId>
            <ArticleId IdType="pubmed">33806031</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nurmohamed M.T., Dijkmans B. Efficacy, tolerability and cost effectiveness of disease-modifying antirheumatic drugs and biologic agents in rheumatoid arthritis. Drugs. 2005;65:661–694.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15748099</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aggarwal B.B., Sethi G., Baladandayuthapani V., Krishnan S., Shishodia S. Targeting cell signaling pathways for drug discovery: an old lock needs a new key. J. Cell. Biochem. 2007;102:580–592.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17668425</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vázquez-González M., Torrente-Rodríguez R.M., Kozell A., Liao W.C., Cecconello A., Campuzano S., Pingarrón J.M., Willner I. Mimicking peroxidase activities with prussian blue nanoparticles and their cyanometalate structural analogues. Nano Lett. 2017;17:4958–4963.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28656770</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang W., Hu S., Yin J.J., He W.W., Lu W., Ma M., Gu N., Zhang Y. Prussian blue nanoparticles as multienzyme mimetics and reactive oxygen species scavengers. JACS. 2016;138:5860–5865.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26918394</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xie X., Zhao J., Gao W., Chen J., Hu B., Cai X., Zheng Y. Prussian blue nanozyme-mediated nanoscavenger ameliorates acute pancreatitis via inhibiting TLRs/NF-κB signaling pathway. Theranostics. 2021;11:3213–3228.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7847676</ArticleId>
            <ArticleId IdType="pubmed">33537083</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Komkova M.A., Karyakina E.E., Karyakin A.A. Catalytically synthesized prussian blue nanoparticles defeating natural enzyme peroxidase. JACS. 2018;140:11302–11307.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30118222</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bai H.Y., Wang T., Kong F., Zhang M.C., Li Z.X., Zhuang L.L., Ma M., Liu F.Z., Wang C., Xu H.Y., Gu N., Zhang Y. CXCR4 and CD44 dual-targeted Prussian blue nanosystem with daunorubicin loaded for acute myeloid leukemia therapy. Chem. Eng. J. 2021;405</Citation>
        </Reference>
        <Reference>
          <Citation>You D.G., Lim G.T., Kwon S., Um W., Oh B.H., Song S.H., Lee J., Jo D.G., Cho Y.W., Park J.H. Metabolically engineered stem cell-derived exosomes to regulate macrophage heterogeneity in rheumatoid arthritis. Sci. Adv. 2021;7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8172131</ArticleId>
            <ArticleId IdType="pubmed">34078596</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wright H.L., Moots R.J., Edwards S.W. The multifactorial role of neutrophils in rheumatoid arthritis. Nat. Rev. Rheumatol. 2014;10:593–601.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24914698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Q.Z., Dehaini D., Zhang Y., Zhou J., Chen X.Y., Zhang L.F., Fang R.H., Gao W.W., Zhang L.F. Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis. Nat. Nanotechnol. 2018;13:1182–1190.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30177807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Headland S.E., Jones H.R., Norling L.V., Kim A., Souza P.R., Corsiero E., Gil C.D., Nerviani A., Accio F.D., Pitzalis C., Oliani S.M., Jan L.Y., Perretti M. Neutrophil-derived microvesicles enter cartilage and protect the joint in inflammatory arthritis. Sci. Transl. Med. 2015;7 315ra190-315ra190.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6034622</ArticleId>
            <ArticleId IdType="pubmed">26606969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Théry C., Zitvogel L., Amigorena S. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2002;2:569–579.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12154376</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalluri R., LeBleu V.S. The biology, function, and biomedical applications of exosomes. Science. 2020;367:1–15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7717626</ArticleId>
            <ArticleId IdType="pubmed">32029601</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun D., Zhuang X., Xiang X., Liu Y., Zhang S., Liu C., Barnes S., Grizzle W., Miller D., Zhang H.G. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol. Ther. 2010;18:1606–1614.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2956928</ArticleId>
            <ArticleId IdType="pubmed">20571541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xue J., Zhao Z., Zhang L., Xue L., Shen S., Wen Y., Wei Z., Wang L., Kong L., Sun H., Zhang C. Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence. Nat. Nanotechnol. 2017;12:692–700.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28650441</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang L., Zhang Y., Xue Y., Wu Y., Wang Q., Xue L., Zhang C. Transforming weakness into strength: photothermal‐therapy‐induced inflammation enhanced cytopharmaceutical chemotherapy as a combination anticancer treatment. Adv. Mater. 2019;31</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30537012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abbasi M., Mousavi M.J., Jamalzehi S., Alimohammadi R., Bezvan M.H., Mohammadi H., Aslani S. Strategies toward rheumatoid arthritis therapy; the old and the new. J. Cell. Physiol. 2019;234:10018–10031.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30536757</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feldmann M. Development of anti-TNF therapy for rheumatoid arthritis. Nat. Rev. Immunol. 2002;2:364–371.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12033742</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roubille1 C., Richer V., Starnino T., McCourt C., McFarlane A., Fleming P., Siu S., Kraft J., Lynde C., Pope J., Gulliver W., Keeling S., Dutz J., Bessette L., Bissonnette R., Haraoui B. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. ARD (Ann. Rheum. Dis.) 2015;74:480–489.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4345910</ArticleId>
            <ArticleId IdType="pubmed">25561362</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li J., Chen L., Xu X., Fan Y., Xue X., Shen M., Shi X. Targeted combination of antioxidative and anti‐inflammatory therapy of rheumatoid arthritis using multifunctional Dendrimer‐Entrapped gold nanoparticles as a platform. Small. 2020;16</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33205596</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang Y., Guo L., Wang Z., Liu P., Liu X., Ding J., Zhou W. Targeted silver nanoparticles for rheumatoid arthritis therapy via macrophage apoptosis and Re-polarization. Biomaterials. 2021;264</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32980634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ni R., Song G., Fu X., Song R., Li L., Pu W., Gao J., Hu J., Liu Q., He F., Zhang D., Huang G. Reactive oxygen species-responsive dexamethasone-loaded nanoparticles for targeted treatment of rheumatoid arthritis via suppressing the iRhom2/TNF-α/BAFF signaling pathway. Biomaterials. 2020;232</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31918224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu M., Huang Y. Bioinspired exosome-like therapeutics and delivery nanoplatforms. Biomaterials. 2020;242</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32151860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smolen J.S., Aletaha D. Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges. Nat. Rev. Rheumatol. 2015;11:276–289.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25687177</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weyand C., Goronzy J. Immunometabolism in early and late stages of rheumatoid arthritis. Nat. Rev. Rheumatol. 2017;13:291–301.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6820517</ArticleId>
            <ArticleId IdType="pubmed">28360422</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qin Z., Chen B., Mao Y., Shi C., Li Y., Huang X., Yang F., Gu N. Achieving ultrasmall prussian blue nanoparticles as high-performance biomedical agents with multifunctions. ACS Appl. Mater. Interfaces. 2020;12:57382–57390.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33295749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tian T., Zhang H.X., He C.P., Fan S., Zhu Y.L., Qi C., Huang N.P., Xiao Z.D., Lu Z.H., Tannous B.A., Gao J. Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy. Biomaterials. 2018;150:137–149.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29040874</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brand D., Latham K., Rosloniec E. Collagen-induced arthritis. Nat. Protoc. 2007;2:1269–1275.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17546023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buckley C.D., Ospelt C., Gay S., Midwood K.S. Location, location, location: how the tissue microenvironment affects inflammation in RA. Nat. Rev. Rheumatol. 2021;17:1–18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33526927</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Metzler K.D., Fuchs T.A., Nauseef W.M., Reumaux D., Roesler J., Schulze I., Wahn V., Papayannopoulos V., Zychlinsky A. Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity. Blood. 2011;117:953–959.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3035083</ArticleId>
            <ArticleId IdType="pubmed">20974672</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Familtseva A., Jeremic N., Tyagi S.C. Exosomes: cell-created drug delivery systems. Mol. Cell. Biochem. 2019;459:1–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31073888</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang W., Zhang L., Cheng C., Shan W., Ma R., Yin Z., Zhu C. Parallel comparison of fibroblast-like synoviocytes from the surgically removed hyperplastic synovial tissues of rheumatoid arthritis and osteoarthritis patients. Bmc. Musculoskel. Discord. 2019;20:1–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6898940</ArticleId>
            <ArticleId IdType="pubmed">31812161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pirozzi C., Francisco V., Di Guida F., Gómez R., Lago F., Pino J., Meli R., Gualillo O. Butyrate modulates inflammation in chondrocytes via GPR43 receptor. Cell. Physiol. Biochem. 2018;51:228–243.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30448827</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dalal P.J., Sumagin R. Emerging functions of ICAM-1 in macrophage efferocytosis and wound healing. J. Cell. Immunol. 2020;2:250–253.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7793567</ArticleId>
            <ArticleId IdType="pubmed">33426539</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wright H.L., Moots R.J., Edwards S.W. The multifactorial role of neutrophils in rheumatoid arthritis. Nat. Rev. Rheumatol. 2014;10:593–601.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24914698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wipke B.T., Allen P.M. Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J. Immunol. 2001;167:1601–1608.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11466382</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qin Z.G., Li Y., Gu N. Progress in applications of Prussian blue nanoparticles in biomedicine. Adv. Healthc. Mater. 2018;7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29974662</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fukai T., Ushio-Fukai M. Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxidants Redox Signal. 2011;15:1583–1606.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3151424</ArticleId>
            <ArticleId IdType="pubmed">21473702</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tarafdar A., Pula G. The role of NADPH oxidases and oxidative stress in neurodegenerative disorders. Int. J. Mol. Sci. 2018;19:3824.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6321244</ArticleId>
            <ArticleId IdType="pubmed">30513656</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ishihara Y., Takemoto T., Itoh K., Ishida A., Yamazaki T. Dual role of superoxide dismutase 2 induced in activated microglia: oxidative stress tolerance and convergence of inflammatory responses. J. Biol. Chem. 2015;290:22805–22817.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4566251</ArticleId>
            <ArticleId IdType="pubmed">26231211</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li C., Ma D., Chen M., Zhang L., Zhang L., Zhang J., Zhang J., Qu X., Wang C. Ulinastatin attenuates LPS-induced human endothelial cells oxidative damage through suppressing JNK/c-Jun signaling pathway. Biochem. Biophys. Res. Commun. 2016;474:572–578.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27109479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu D.H., Yi J.K., Yuh H.S., Kim H.J., Bae K.B., Ji Y.R., Kim N.R., Park S.J., Kim D.H., Kim S.H., Kim M.O., Lee J.W., Ryoo1 Z.Y. Over-expression of extracellular superoxide dismutase in mouse synovial tissue attenuates the inflammatory arthritis. Exp. Mol. Med. 2012;44:529–535.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3465746</ArticleId>
            <ArticleId IdType="pubmed">22718219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qu Z., Meng F., Zhou H., Li J., Wang Q., Wei F., Cheng J., Greenlief C.M., Lubahn D.B., Sun G.Y., Liu S., Gu Z. NitroDIGE analysis reveals inhibition of protein S-nitrosylation by epigallocatechin gallates in lipopolysaccharide-stimulated microglial cells. J. Neuroinflammation. 2014;11:1–13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3922161</ArticleId>
            <ArticleId IdType="pubmed">24472655</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang T., Qin L., Liu B., Liu Y., Wilson B., Eling T.E., Langenbach R., Taniura S., Hong J.S. Role of reactive oxygen species in LPS‐induced production of prostaglandin E2 in microglia. J. Neurochem. 2004;88:939–947.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14756815</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park J., Min J.S., Kim B., Chae U.B., Yun J.W., Choi M.S., Kong I.K., Chang K.T., Lee D.S. Mitochondrial ROS govern the LPS-induced pro-inflammatory response in microglia cells by regulating MAPK and NF-κB pathways. Neurosci. Lett. 2015;584:191–196.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25459294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li S., Chen J.W., Xie X., Tian J., Deng C., Wang J., Gan H.N., Li F. Autophagy inhibitor regulates apoptosis and proliferation of synovial fibroblasts through the inhibition of PI3K/AKT pathway in collagen-induced arthritis rat model. Am. J. Transl. Res. 2017;9:2065.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5446493</ArticleId>
            <ArticleId IdType="pubmed">28559961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wong C.K., Chen D.P., Tam L.S., Edmund K.L., Yi Y.B., Christopher W.L. Effects of inflammatory cytokine IL-27 on the activation of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res. Ther. 2010;12:1–15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2945019</ArticleId>
            <ArticleId IdType="pubmed">20604932</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jing W., Sun W., Zhang N., Zhao C., Yan X. The protective effects of the GPR39 agonist TC-G 1008 against TNF-α-induced inflammation in human fibroblast-like synoviocytes (FLSs) Eur. J. Pharmacol. 2019;865</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31539553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peng M., Qiang L., Xu Y., Li C., Li T., Wang J. IL‐35 ameliorates collagen‐induced arthritis by promoting TNF‐α‐induced apoptosis of synovial fibroblasts and stimulating M2 macrophages polarization. FEBS J. 2019;286:1972–1985. 2019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30834683</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mehta P., Porter J.C., Manson J.J., Isaacs J.D., Openshaw P.J.M., McInnes I.B., Summers C., Chambers R.C. Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities. Lancet Respir. Med. 2020;8:822–830.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7834476</ArticleId>
            <ArticleId IdType="pubmed">32559419</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hamilton J.A. GM-CSF-dependent inflammatory pathways. Front. Immunol. 2019;10:2055.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6737278</ArticleId>
            <ArticleId IdType="pubmed">31552022</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park J., Ha S.H., Abekura F., Lim H., Magae J., Ha K.T., Chung T.W., Chang Y.C., Lee Y.C., Chung E., Ku J., Kim C.H. 4-O-Carboxymethylascochlorin inhibits expression levels of on inflammation-related cytokines and matrix metalloproteinase-9 through NF–κB/MAPK/TLR4 signaling pathway in LPS-activated RAW264. 7 cells. Front. Pharmacol. 2019;10:30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6445864</ArticleId>
            <ArticleId IdType="pubmed">31001118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mantovani A., Dinarello C.A., Molgora M., Garlanda C. Interleukin-1 and related cytokines in the regulation of inflammation and immunity. Immunity. 2019;50:778–795.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7174020</ArticleId>
            <ArticleId IdType="pubmed">30995499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shimba A., Cui G., Tani-Ichi S., Ogawa M., Abe S., Okazaki F., Kitano S., Miyachi H., Yamada H., Hara T., Yoshikai Y., Nagasawa T., Schütz G., Ikuta K. Glucocorticoids drive diurnal oscillations in T cell distribution and responses by inducing interleukin-7 receptor and CXCR4. Immunity. 2018;48:286–298.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29396162</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen J., Chung D.W. Inflammation, von Willebrand factor, and ADAMTS13. Blood. 2018;132:141–147.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6043979</ArticleId>
            <ArticleId IdType="pubmed">29866815</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mandal C.C., Choudhury G.G., Ghosh-Choudhury N. Phosphatidylinositol 3 kinase/Akt signal relay cooperates with smad in bone morphogenetic protein-2-induced colony stimulating factor-1 (CSF-1) expression and osteoclast differentiation. Endocrinology. 2009;150:4989–4998.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2775973</ArticleId>
            <ArticleId IdType="pubmed">19819979</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Teng P., Liu Y., Dai Y., Zhang H., Liu W.T., Hu J. Nicotine attenuates osteoarthritis pain and matrix metalloproteinase-9 expression via the α7 nicotinic acetylcholine receptor. J. Immunol. 2019;203:485–492.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31152077</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma J., Sun X., Guo T., Su H., Chen Q., Gong Z., Qi J., Zhao X. Interleukin-1 receptor antagonist inhibits angiogenesis via blockage IL-1α/PI3K/NF-κβ pathway in human colon cancer cell. Cancer Manag. Res. 2017;9:481–493.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5640395</ArticleId>
            <ArticleId IdType="pubmed">29062241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang L., Guo X.G., Du C.Q., Yang J.X., Jiang D.M., Li B., Zhou W.J., Zhang F.R. Interleukin-1 beta increases activity of human endothelial progenitor cells: involvement of PI3K-Akt signaling pathway. Inflammation. 2012;35:1242–1250.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22371121</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jian M., Yunjia Z., Zhiying D., Yanduo J., Guocheng J. Interleukin 7 receptor activates PI3K/Akt/mTOR signaling pathway via downregulation of Beclin‐1 in lung cancer. Mol. Carcinog. 2019;58:358–365.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30362635</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fang J., Sun X., Liu S., Yang P., Lin J., Feng J., Cruz M.A., Dong J., Fang Y., Wu J. Shear Stress Accumulation enhances von Willebrand factor-induced platelet P-selectin translocation in a PI3K/Akt pathway-dependent manner. Front. Cell Dev. Biol. 2021;9:64218.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8204100</ArticleId>
            <ArticleId IdType="pubmed">34141704</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jin S., Chen H., Li Y., Zhong H., Sun W., Wang J., Zhang T., Ma J., Yan S., Zhang J.J. Maresin 1 improves the Treg/Th17 imbalance in rheumatoid arthritis through miR-21. ARD (Ann. Rheum. Dis.) 2018;77:1644–1652.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30045854</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Evans C.H., Kraus V.B., Setton L.A. Progress in intra-articular therapy. Nat. Rev. Rheumatol. 2014;10:11–22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4402210</ArticleId>
            <ArticleId IdType="pubmed">24189839</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
